Loading...
Loading...
BIMI| Name | Value |
|---|---|
| Revenues | 3,197.6K |
| Cost of Revenue | 1,507.4K |
| Gross Profit | 1,690.2K |
| Operating Expense | 1,109.5K |
| Operating I/L | 580.7K |
| Other Income/Expense | -1,441.4K |
| Interest Income | 0.3K |
| Pretax | -860.6K |
| Income Tax Expense | 23.6K |
| Net Income/Loss | -884.2K |
BIMI International Medical Inc. operates in the retail and wholesale distribution of medical devices, pharmaceuticals, and healthcare products in the People's Republic of China. The company's segments include Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes a range of medical products, including Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to various healthcare facilities. Additionally, it offers a wide range of pharmaceutical products, including generic drugs, Chinese herbal medicine, biochemical drugs, and over-the-counter medications. The company also provides medical services and IT research and development services.
